Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study.
Escudero-Sanchez R, Muriel García A, García Fernández S, Valencia Alijo A, Tasias Pitarch M, Merino De Lucas E, Gutierrez Rojas A, Ramos Martínez A, Salavert Lletí M, Giner L, Ruíz Ruigomez M, García Basas L, Fernández Fradejas J, Olmedo Sampedrio M, Cano Yuste A, Díaz Pollán B, Rodríguez Hernández MJ, Martín Segarra O, Sáez Bejar C, Armiñanzas Castillo C, Gutiérrez B, Rodríguez-Pardo D, De La Torre Cisneros J, López Medrano F, Cobo Reinoso J. Escudero-Sanchez R, et al. Among authors: cano yuste a. J Antimicrob Chemother. 2022 Jun 29;77(7):1996-2002. doi: 10.1093/jac/dkac106. J Antimicrob Chemother. 2022. PMID: 35403189
Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection.
Escudero-Sánchez R, Ruíz-Ruizgómez M, Fernández-Fradejas J, García Fernández S, Olmedo Samperio M, Cano Yuste A, Valencia Alijo A, Díaz-Pollán B, Rodríguez Hernández MJ, Merino De Lucas E, Martín Segarra O, Sáez Bejar C, Armiñanzas Castillo C, Gutiérrez Gutiérrez B, Rodríguez-Pardo D, Ramos Martínez A, De La Torre Cisneros J, López-Medrano F, Cobo Reinoso J. Escudero-Sánchez R, et al. Among authors: cano yuste a. J Clin Med. 2020 Dec 22;10(1):2. doi: 10.3390/jcm10010002. J Clin Med. 2020. PMID: 33374989 Free PMC article.
Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial.
Sojo-Dorado J, López-Hernández I, Rosso-Fernandez C, Morales IM, Palacios-Baena ZR, Hernández-Torres A, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Giner-Oncina L, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Alvarez RM, Dueñas CJ, Calvo-Montes J, Silva JT, Cárdenes MA, Lecuona M, Pomar V, Valiente de Santis L, Yagüe-Guirao G, Lobo-Acosta MA, Merino-Bohórquez V, Pascual A, Rodríguez-Baño J; REIPI-GEIRAS-FOREST group. Sojo-Dorado J, et al. JAMA Netw Open. 2022 Jan 4;5(1):e2137277. doi: 10.1001/jamanetworkopen.2021.37277. JAMA Netw Open. 2022. PMID: 35024838 Free PMC article. Clinical Trial.
Predictors of success of high-flow nasal cannula in the treatment of acute hypoxemic respiratory failure.
Artacho Ruiz R, Artacho Jurado B, Caballero Güeto F, Cano Yuste A, Durbán García I, García Delgado F, Guzmán Pérez JA, López Obispo M, Quero Del Río I, Rivera Espinar F, Del Campo Molina E. Artacho Ruiz R, et al. Among authors: cano yuste a. Med Intensiva (Engl Ed). 2021 Mar;45(2):80-87. doi: 10.1016/j.medin.2019.07.012. Epub 2019 Aug 24. Med Intensiva (Engl Ed). 2021. PMID: 31455561 Free article. English, Spanish.